Brind.

Teva reported a 3% revenue growth in its Europe segment as of July 30, 2025.

2 reports, 2 independent Updated Jul 30

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Teva reported a 3% revenue growth in its Europe segment as of July 30, 2025.

Who's involved

What this event is mainly about

Europe Teva Pharmaceutical Industries Ltd.

Keep exploring

The entities involved

Europe
terrestrial continent located in north-western Eurasia
- ClientEarth and World Resources Institute produced an air quality report, and ClientEarth addressed EU air pollution laws.04:01
- The UK has reported high asthma mortality rates across Europe.03:32
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
- Brian transitioned from a senior leadership role at Teva Pharmaceuticals to join Lupin Limited, where Vinita Gupta is CEO.Fri 11:19
- Deckers Brands reported strong earnings driven by Ugg and Hoka, while Stefano Caroti was named CEO of the company.Fri 02:46

Related events

Coverage

Newest first; wire copies grouped

Jul 30GlobeNewswireTeva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components On track for 30
Jul 30Business WireHayward Holdings Reports Second Quarter Fiscal Year 2025 Financial Results and Refines 2025 Guidance SECOND QUARTER FISCAL 2025 SUMMARY Net Sales increased 5% year-over-year to $299.6 million Net Inc